Uniqure N.V. (QURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | QURE | NTLA | RAPP | ||
| Company | Uniqure N.V. | Intellia Thera CS | Rapport Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.11 | 12.51 | 29.80 | ||
| High | 24.09 | 13.13 | 31.50 | ||
| Low | 23.02 | 12.41 | 29.34 | ||
| Latest | 23.68 | 12.58 | 29.82 | ||
| Change | +0.25 | -0.06 | +0.06 | ||
| % Change | +1.07% | -0.47% | +0.20% | ||
| Volume | 643,863 | 840,601 | 151,563 | ||
| 20-Day Average Volume | 1,808,172 | 4,323,530 | 331,547 | ||
| Previous Close | 23.43 | 12.64 | 29.76 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.13 | 12.72 | 27.73 | ||
| 20-Day Raw Stochastic | 40.79% | 28.06% | 71.28% | ||
| 20-Day Relative Strength | 48.15 | 52.86 | 56.01 | ||
| Weighted Alpha | -7.90 | +104.78 | +75.42 | ||
| Today's Opinion | 48% Sell | 16% Sell | 88% Buy | ||
| Previous Opinion | 48% Sell | 16% Sell | 72% Buy | ||
| Last Month's Opinion | 72% Sell | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.93% since 02/13/26 | +6.67% since 02/13/26 | +5.94% since 02/13/26 | ||
| Low | 20.25 on 02/17/26 | 11.66 on 02/17/26 | 26.78 on 02/20/26 | ||
| High | 24.98 on 02/18/26 | 13.13 on 02/23/26 | 31.35 on 02/23/26 | ||
| 1-Month | |||||
| %Chg | -6.06% since 01/23/26 | -13.45% since 01/23/26 | +9.88% since 01/23/26 | ||
| Low | 20.17 on 02/13/26 | 10.94 on 02/05/26 | 25.21 on 02/05/26 | ||
| High | 28.48 on 02/03/26 | 17.09 on 01/27/26 | 31.35 on 02/23/26 | ||
| 3-Month | |||||
| %Chg | -15.28% since 11/21/25 | +54.23% since 11/21/25 | +8.59% since 11/21/25 | ||
| Low | 19.29 on 12/15/25 | 8.09 on 12/02/25 | 25.21 on 02/05/26 | ||
| High | 29.99 on 11/24/25 | 17.09 on 01/27/26 | 32.36 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +50.06% since 08/22/25 | +20.36% since 08/22/25 | +100.34% since 08/22/25 | ||
| Low | 13.65 on 09/23/25 | 7.95 on 11/21/25 | 14.11 on 09/04/25 | ||
| High | 71.50 on 10/28/25 | 28.25 on 10/20/25 | 42.27 on 09/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,459,501 | 1,464,091 | 1,418,391 | ||
| Shares Outstanding, K | 62,292 | 115,830 | 47,661 | ||
| Annual Sales | 27,120,000 | 57,880,000 | 0 | ||
| Annual Net Income | -239,560,000 | -519,020,000 | -78,310,000 | ||
| Last Quarter Sales | 3,700,000 | 13,780,000 | 0 | ||
| Last Quarter Net Income | -80,530,000 | -101,320,000 | -26,930,000 | ||
| 60-Month Beta | 0.66 | 2.10 | 1.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.38 on 11/10/25 | -0.92 on 11/06/25 | -0.71 on 11/06/25 | ||
| Latest Earnings Date | 02/26/26 | 02/26/26 | 03/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||